Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Changes in Coronary Collateral Function Post CTO Intervention

In the last few years, we have seen significant growth of chronic total occlusion (CTO) percutaneous intervention, which has also been considered for patients with viable territory that remain symptomatic. Experienced centers present successful CTO intervention rates close to 90%, especially with a hybrid approach. However, it is still a complex procedure, and target vessel failure rate (TVF) remains high. 

Disnea y oclusiones totales crónicas: un síntoma que podemos aliviar (o al menos intentarlo)

CTO Percutaneous intervention (PCI) can generate changes in coronary circulation that could be classified as: 1) effects on CTO vessel and dependent myocardium, 2) effects on donor vessels, and 3) effects on the interaction between these two (collateral circulation). 

A small group of patients saw changes after CTO PCI: increased absolute blood flow (Q) and FFR in CTO vessel, with reduced myocardium resistance. Also, there was reduced collateral vessel flow, regressing over time, while when looking at donor artery, there was increased FFR with reduced flow and increased resistance (collateral loss). 

The aim of this study, carried out in three European centers, was to look into changes in collateral flow after CTO PCI and identify whether there were associated to recanalization technique. 

Lea también: Stents finos vs ultrafinos: Resultados clínicos a 1 año cuando se implantan guiado por IVUS/OCT.

A prospective observational study was carried out of patients with viable compromised territory presenting angiographically visible collateral circulation. CTO techniques were wire escalation, and dissection and re-entry, both anterograde and retrograde. After successful PCI coronary physiology was measured through FFR, coronary wedge pressure (PW), and flow measurement with three FFR data (FFRmio=FFRcor+FFRcoll). Q was calculated with continuous coronary thermodilution. 

Of 119 CTO PCI, 106 were successful (89% successful rate), 81 patients were included in the final cohort and followup at 3 months. Mean age was 64, 82% were men, J-CTO score was 2 and 22% presented EURO-CASTLE score >3.  64% received anterograde escalation, 8.6% dissection and re-entry and 27% retrograde. 

PW saw 0.34±0.11 to 0.19±0.09 (p<0.01) reduction between post CTO PCI and followup data, also resting values reduced from 0.40±0.14 to 0.17±0.09 (p<0.01). Absolute difference between resting and hyperemia values gradually reduced at followup, which speaks of micro vessel recovery over time (0.17±0.09 vs 0.19±0.09), though not significant. Maximum collateral flow (Qcol) reduced from 55±32 ml/min post PCI to 38±24 ml/min (p<0.01). While CTO Q after PCI went from 210±87 ml/min to 255±99 ml/min at followup (p<0.01). Multivariable analyzis showed no difference in change associated to PCI strategy. 

Conclusions

This study is the largest to analyze physiological changes in collateral circulation after CTO PCI, both in pressure and flow. There was a significant reduction of collateral flow between index procedure and 3-month followup values, regardless of technique. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention

Source: Keulards D, Alsanjari O, Keeble TR, Vlaar P-J, Kelly PA, Tang KH, et al. Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention [Internet]. Pcronline.com. [citado 13 de julio de 2022].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...